---
title: DDW Fall Issue 2026
description: DDW Fall Issue 2026
image: https://info.edifydigitalmedia.com/hubfs/DDW-Fall_2026_Feature-Image_366px.jpg
---

[Skip to content](https://info.edifydigitalmedia.com#main-content)

[![DDW Hi Res Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW%20Hi%20Res%20Logo.jpg?width=250&height=118&name=DDW%20Hi%20Res%20Logo.jpg "DDW Hi Res Logo")](https://www.edifydigitalmedia.com/)

![DDII - 2026 - Hubspot Landing pg banner\_London](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDII%20-%202026%20-%20Hubspot%20Landing%20pg%20banner_London.jpg?width=1425&height=400&name=DDII%20-%202026%20-%20Hubspot%20Landing%20pg%20banner_London.jpg "DDII - 2026 - Hubspot Landing pg banner_London")

Drug Discovery World is the media partner for the *Drug Discovery Innovators & Investors* conference on the 4th of November 2026 at etc.venues Monument, London, UK. Breakfast, lunch and refreshment breaks are included, and the day closes with a networking drinks reception.

If you would like to attend as DDW's guest please register and we will be in touch if you qualify.

- **9:00** Registration, Welcome & Networking
- **10:00** Panel Discussion: Get It Done: Designing Faster, More Effective UK Clinical Trials. *Janet Hemingway**,** Founding director, iiCON - Infection Innovation Consortium, Phillippa Brown, Head of Development Operations, GSK*
- **11:00** Expert Presentations: From Rules to Runway: How UK Regulation Can Accelerate or Obstruct Drug Development. *Anusha Foy, VP - Regulatory Affairs, Allucent*
- **11:30** Structured & Informal Networking, including pre-booked 1:1 meetings
- **12:15** Breakout Sessions A: Topics such as AI in drug discovery, AI integration in biotech & pharma, and IP strategy for investors. *Tim Reason (Founder, Estima Scientific), Dr Paul Brooks (CN Bio Innovations), Dr Andrew Wells (Partner and Head of Chemistry, HGF) and Yogan Patel (Head of Life Sciences & MedTech and Partner, MHA)*
- Lunch & Networking, including pre-booked 1:1 meetings
- **1:45** Breakout Sessions B (See Session A)
- **2:15** Structured & Informal Networking, including pre-booked 1:1 meetings
- **2:45** Keynote: Chris Molloy, CEO, UK BioIndustry Association (BIA)
- **3:15** Panel: Where Is the Money? Funding Early-Stage UK Drug Development in a Difficult Market. *Sam Goldsmith, Head of Venture Creation, Cell and Gene Therapy Catapult, Ayokunmi Ajetunmobi, Head of Ventures, Pioneer Group, Tanya Moore, Investment Principal, Cancer Research Horizons' Ventures team, Sinclair Dunlop, Managing Partner, Epidarex; One Life Sciences Board Member*
- **4:00** Networking Reception & Drinks

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Copyright 2026 Drug Discovery World. All Rights Reserved  
[Privacy Policy & Cookies](https://www.ddw-online.com/privacy-policy/) | [Contact](https://info.edifydigitalmedia.com/hubfs/In%20Focus%20eReport_Mar26_Antibody-based%20drugs.pdf?hsLang=en) | [Terms & Conditions](https://www.ddw-online.com/terms-and-conditions/)